Oxcarbazepine

CAS 28721-07-5 24 current records 8 historicalSmall Molecule

Who holds supplier records for Oxcarbazepine? 24 organisations hold a current record for Oxcarbazepine: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 15 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (16), Italy (2), China (2), Israel (1) and 1 other country (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Oxcarbazepine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/oxcarbazepine

Reading the evidence

  • 24 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    16 of the 22 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 12 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Oxcarbazepine expires 13 Apr 2027. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (24)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Oxcarbazepine. Country is the organisation's recorded country, not necessarily the manufacturing site.

India16Italy2China2Israel1Poland1Country not recorded for 2
Need Oxcarbazepine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (15)

Certificates of Suitability on the EDQM register for Oxcarbazepine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 18 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
CEP 2025-115 - Rev 01
Oxcarbazepine, Code 1138 milled grade
Jun 2026Inspected Apr 2026
Italy
DASAMI LAB PRIVATE LIMITED NalgondaIN
CEP 2023-348 - Rev 02
Oxcarbazepine, Process-II
May 2026Inspected Sept 2024
Hungary
ASSURGEN PHARMA PRIVATE LIMITED VisakhapatnamIN
CEP 2023-450 - Rev 01
Oxcarbazepine
Apr 2026Inspected May 2023
Hungary, outside 3-year window
ZHEJIANG JIUZHOU PHARMACEUTICAL CO. LTD. TaizhouCN
CEP 2022-230 - Rev 03
Oxcarbazepine
Feb 2026Inspected Nov 2025
Hungary
HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. EzhouCN
CEP 2018-165 - Rev 05
Oxcarbazepine, Micronised and non-micronised
Feb 2026Inspected Nov 2023
Germany
BAJAJ HEALTHCARE LIMITED ThaneIN
CEP 2021-340 - Rev 01
Oxcarbazepine
Sept 2025—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2013-181 - Rev 03
Oxcarbazepine
Sept 2025—
JUBILANT BIOSYS LIMITED NanjangudIN
CEP 2014-059 - Rev 04
Oxcarbazepine
Sept 2025—
MSN LIFE SCIENCES PRIVATE LIMITED MedakIN
CEP 2024-309 - Rev 00
Oxcarbazepine, Micronised and non-micronised
Jul 2025Inspected Oct 2025
Slovakia
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2022-458 - Rev 00
Oxcarbazepine
May 2025—
ARENE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2024-343 - Rev 00
Oxcarbazepine
Apr 2025—
AMI LIFESCIENCES PRIVATE LIMITED KarakhadiIN
CEP 2022-108 - Rev 02
Oxcarbazepine
Jan 2025Inspected Oct 2025
Slovakia
CTX LIFESCIENCES PVT. LIMITED SuratIN
CEP 2018-113 - Rev 02
Oxcarbazepine
Aug 2024—
AURORE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2022-155 - Rev 00
Oxcarbazepine
Sept 2023—
AMOLI ORGANICS PRIVATE LIMITED MumbaiIN
R1-CEP 2016-211 - Rev 00
Oxcarbazepine
Oct 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Oxcarbazepine are no longer active. These show a past filing, not current supply.

Show all 8 historical records
  • KONDUSKAR LABORATORIES PVT LTD
    Inactive DMF 26027 · filed Apr 2012
  • MATRIX LABORATORIES LTD
    Inactive DMF 22370 · filed Dec 2008
  • FABBRICA ITALIANA SINTETICI SPA
    Inactive DMF 18521 · filed Jun 2005
  • ERREDUE SPA INNOVATIVE CHEMICAL AND LIFE
    Inactive DMF 18383 · filed Jun 2005
  • India · Inactive DMF 18381 · filed May 2005
  • Italy · Inactive DMF 17488 · filed Jun 2004
  • BASF ORGAMOL PHARMA SOLUTIONS SA
    Inactive DMF 17029 · filed Jan 2004
  • FARCHEMIA SRL
    Inactive DMF 15889 · filed Mar 2002

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (61 listed products contain Oxcarbazepine). The latest listed patent expires 13 Apr 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Oxcarbazepine is an anticonvulsant and mood-stabilizing drug, used primarily in the treatment of epilepsy. It works by blocking sodium channels and stabilizing hyperexcited nerve cell membranes.

Chemical identity

IUPAC name
5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
Canonical SMILES
C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
InChIKey
CTRLABGOLIVAIY-UHFFFAOYSA-N
Synonyms
Trileptal API, gp-47680, kin-493, nsc-758693, oxtellar xr, oxcarbamazepine, spn-804, trileptal

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Anti-epileptic Agent
Physiologic effect
Decreased Central Nervous System Disorganized Electrical Activity

Therapeutic areas

NeurologyPsychiatry

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Oxcarbazepine?

24 organisations hold an active US FDA Type II Drug Master File or a CEP for Oxcarbazepine: DASAMI LAB PRIVATE LTD (India), AMI LIFESCIENCES PRIVATE LTD (India), Arene Life Sciences Limited (India), Aurore Life Sciences (India), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (China), JUBILANT BIOSYS LTD (India) and MSN LIFE SCIENCES PRIVATE LIMITED (India), and 16 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Oxcarbazepine Drug Master Files are active?

DASAMI LAB PRIVATE LTD (DMF 35190, 31525), AMI LIFESCIENCES PRIVATE LTD (DMF 38017), Arene Life Sciences Limited (DMF 43632), Aurore Life Sciences (DMF 34484), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 16597), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (DMF 32999), JUBILANT BIOSYS LTD (DMF 16430) and MSN LIFE SCIENCES PRIVATE LIMITED (DMF 33274) and 10 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Oxcarbazepine records mean?

8 organisations have only inactive Type II DMFs for Oxcarbazepine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Oxcarbazepine have a European Certificate of Suitability?

Yes. 15 organisations hold a valid CEP for Oxcarbazepine on the EDQM register, including F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore (IT), DASAMI LAB PRIVATE LIMITED Nalgonda (IN), ASSURGEN PHARMA PRIVATE LIMITED Visakhapatnam (IN), ZHEJIANG JIUZHOU PHARMACEUTICAL CO. LTD. Taizhou (CN), HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou (CN) and BAJAJ HEALTHCARE LIMITED Thane (IN) and 9 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Oxcarbazepine?

Yes. The latest patent listed for an approved US product containing Oxcarbazepine expires 13 Apr 2027, across 61 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Oxcarbazepine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Oxcarbazepine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.